Method for determining purity of enantiomer of analyte
Through ion mobility separation technology and self-dimerization phenomenon, the enantiomer purity is determined by using the mobility peak area ratio of the dimer, which solves the problem of difficulty in distinguishing enantiomers in the prior art and achieves rapid , reliable analysis results.
Patent Information
- Application Number
- CN202380028206.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-17
- Filing Date
- 2023-03-16
- Publication Date
- 2024-11-01
AI Technical Summary
The prior art is difficult to quickly and reliably distinguish and determine the purity of enantiomers in chemistry, especially in the pharmaceutical industry, where traditional methods require chiral probes and modifiers, and commercial IMS systems cannot effectively isolate enantiomers. Construct.
Through ion mobility separation technology, ionization analytes form dimer ions, and the purity of enantiomers is determined by the mobility peak area ratio of different dimers, and chiral distinction is achieved in IMS using the self-dimerization phenomenon , avoiding dependence on chiral selective agents and gases.
The rapid and reliable distinction and determination of enantiomer purity is achieved without the need for chiral modifiers and gases, improving analysis efficiency and accuracy, and simplifying the pharmaceutical process.
Smart Images

Figure CN118891518A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to and the benefit of UK Patent Application No. 2203746.9 filed on March 17, 2022. The entire contents of this application are incorporated herein by reference. Technical Field
[0003] The present invention relates to a method of determining the enantiomeric purity of an analyte using an analytical instrument, such as a mass and / or ion mobility spectrometer. The present invention also relates to an instrument configured to perform such a method. Background Art
[0004] Determining the enantiomeric purity of a compound is of vital importance in various areas of chemistry, especially in the pharmaceutical industry, where different enantiomers can have very different effects on the body.
[0005] Any chiral identification generally requires a chiral probe. Examples of such probes include circularly polarized light for assessing enantiomeric excess in synthesis, chiral catalysts and reagents in chiral-directed (or enantioselective) synthesis, chiral stationary phases in chiral chromatography, or chiral substrates in chiral NMR.
[0006] Ideally, enantiomers can be distinguished in a relatively fast and easy manner, such as by using an ion mobility separator (IMS) to separate enantiomers. However, enantiomers cannot be separated by ion mobility alone, regardless of the resolution of the IMS device used. This is because enantiomers have the same collision cross section (CCS) and therefore interact with the background gas in the IMS device to the same extent. In theory, some chiral modifier is needed to modify the enantiomers so that they have different mobilities through the IMS device, but this is not yet available on commercial IMS systems.
[0007] Previous studies (Anal. Chem. 2006, 78, 8200-8206) have used S-butanol as a chiral dopant in drift tube ion mobility separations to separate the D and L forms of amino acids. A chiral solvent was added to the background gas of the IMS drift tube, and the transient analyte-solvent complex was said to have different mobilities through the gas, and thus the D and L forms of amino acids could be separated. However, such a technique requires further research to become a reliable enantiomer discrimination technique. Summary of the invention
[0008] In a first aspect, there is provided a method of determining the enantiomeric purity of an analyte, the method comprising:
[0009] ionizing the analyte to form a dimer ion;
[0010] Ions of different dimers of the analyte are separated by ion mobility;
[0011] Detecting a first ion mobility peak corresponding to one or more first dimers and detecting a first ion mobility peak corresponding to one or more first dimers
[0012] a second ion mobility peak of ions of one or more second dimers; and
[0013] The enantiomeric purity of the analyte is determined from the ratio of the peak area of the first ion mobility peak to the peak area of the second ion mobility peak.
[0014] This step of separating dimer ions is performed using an ion mobility separator (IMS). One or more first dimers are eluted from the IMS device at a first time, and these ions (or ions derived therefrom) are detected to form a first ion mobility peak. Similarly, one or more second dimers are eluted from the IMS device at a different second time, and these ions (or ions derived therefrom) are detected to form a second ion mobility peak.
[0015] An IMS device may include an ion guide containing a gas therein and electrodes configured to generate an electric field that drives ions against the gas so that the ions separate according to their mobility through the gas. The ions then elute (ie, leave) the IMS device at different times depending on their mobility.
[0016] The inventors have surprisingly found that self-dimerization of chiral molecules can be used as the basis for chiral discrimination in IMS. Dimerization can give different diastereomers with different collision cross sections and therefore different ion mobilities. This provides the possibility to easily determine enantiomeric purity / excess by IMS without any additional preparation steps, chiral complexing reagents or chiral gases.
[0017] The first ion mobility peak may correspond to a homodimer ion, and the second ion mobility peak may correspond to a heterodimer ion.
[0018] The method may include determining that the peak area of the second mobility peak is equal to or less than the peak area of the first mobility peak, and therefore the first mobility peak corresponds to the ion mobility of the homodimer ion of the analyte, and the second mobility peak corresponds to the heterodimer ion of the analyte.
[0019] The first ion mobility peak may correspond to ions of at least two types of different dimers, and / or the second ion mobility peak may correspond to ions of at least two types of different dimers. For example, the first ion mobility peak may correspond to ions of SS dimers and RR dimers. Additionally or alternatively, the second ion mobility peak may correspond to ions of SR dimers and RS dimers.
[0020] Each of the dimers may be formed from gas phase monomer ions hydrogen bonded to each other.
[0021] The method can be performed in the absence of a chiral selector and / or in the absence of a chiral complexing agent. In other words, a chiral selector and / or a chiral complexing agent is not used to separate different dimers of the analyte. Instead, the ions of the different dimers are desirably separated from each other only by driving the ions through a neutral gas (i.e., a gas that does not chemically react with the dimer ions).
[0022] The step of separating the ions may be performed by an ion mobility separator; wherein the ions eluted from the separator or ions derived therefrom are detected and mass analyzed in a mass analyzer to obtain mass spectral data representing the mass-to-charge ratio of the detected ions, and wherein the mass spectral data of the ions detected at any given time are associated with the elution time of the ions from the separator based on the time at which the mass analyzer detects these ions.
[0023] The mass analyser may be a time of flight ("TOF") mass analyser.
[0024] The mass analyzer may repeatedly mass analyze ions eluted from the IMS device (or ions derived therefrom) at a relatively high rate so as to sample ions (or ions derived therefrom) leaving the ion mobility separator multiple times during each ion mobility peak. The mass analyzer desirably operates at a sufficiently high sampling rate so as to obtain sufficient data points to construct a mobility peak that faithfully represents the intensity distribution of ions eluted from the ion mobility separator as a function of elution time from the separator.
[0025] The method may include filtering mass spectrometry data to obtain only data corresponding to detected ions having a selected mass-to-charge ratio, thereby obtaining filtered data representing the intensity of ions of the selected mass-to-charge ratio as a function of elution time from a separator; and wherein the step of detecting a first ion mobility peak and a second ion mobility peak includes detecting the first ion mobility peak and the second ion mobility peak in the filtered data.
[0026] The step of filtering the mass spectral data may include filtering the mass spectral data to obtain only data corresponding to detected ions having a mass-to-charge ratio equal to the mass-to-charge ratio of one of the dimers.
[0027] The step of filtering the mass spectral data may include filtering the mass spectral data so as to obtain only data corresponding to detected ions having a mass-to-charge ratio equal to the mass-to-charge ratio of a monomer of one of the dimers.
[0028] The method may include selecting whether to use data filtered according to the mass-to-charge ratio of the dimer or data filtered according to the mass-to-charge ratio of the monomer to determine the enantiomeric purity of the analyte. For example, the selection may be made based on determining which of the spectral data has the highest ion abundance. Alternatively, both sets of filtered data may be used.
[0029] The method may include mass filtering the ions and transmitting only ions having a selected mass-to-charge ratio corresponding to the mass-to-charge ratio of one of the dimers to an ion mobility separator which performs the step of separating the ions by ion mobility.
[0030] The first ion mobility peak may correspond to a homodimer ion and the second ion mobility peak may correspond to a heterodimer ion, and the step of determining the enantiomeric purity of the analyte may include: calculating the enantiomeric purity from the ratio of the peak area of the first ion mobility peak to the peak area of the second ion mobility peak using a calibration function, wherein the calibration function accounts for the difference between the association energy of homodimers formed by monomers and the association energy of heterodimers formed by monomers.
[0031] The method may include the following steps: determining a calibration function from a sample with known enantiomeric purity, and calculating the enantiomeric purity from the ratio of the peak area of the first ion mobility peak to the peak area of the second ion mobility peak using the calibration function, wherein the calibration function accounts for the difference between the association energy of homodimers formed by monomers and the association energy of heterodimers formed by monomers.
[0032] The method may be performed on a mass spectrometer having an ion mobility separator and wherein the mass spectrometer has processing circuitry configured to calculate the ratio, such as by dividing the peak area of the first ion mobility peak by the peak area of the second ion mobility peak.
[0033] In a second aspect, there is provided a mass spectrometer for determining the enantiomeric purity of an analyte, the mass spectrometer comprising:
[0034] an ion source for ionizing an analyte;
[0035] an ion mobility separator for separating ions by mobility; and
[0036] A control circuit, the control circuit being configured to:
[0037] controlling the ion source to ionize the analyte;
[0038] controlling an ion mobility separator to separate ions of different dimers of an analyte by ion mobility and obtain mobility spectrum data;
[0039] detecting a first ion mobility peak in the mobility spectrum data corresponding to ions of the one or more first dimers, and detecting a second ion mobility peak in the mobility spectrum data corresponding to ions of the one or more second dimers; and
[0040] The enantiomeric purity of the analyte is determined from the ratio of the peak area of the first ion mobility peak to the peak area of the second ion mobility peak.
[0041] The mass spectrometer can be configured, for example with control circuitry, to perform any of the methods described herein.
[0042] The method can also be applied to other oligomers, such as trimers. Therefore, there is also provided a method for determining the enantiomeric purity of an analyte, the method comprising:
[0043] ionizing the analyte to form oligomer ions (e.g., trimer ions);
[0044] Separating ions of different oligomers (e.g., trimers) of an analyte by ion mobility;
[0045] At least a first ion mobility peak corresponding to ions of one or more first oligomers (e.g., trimers) and a second ion mobility peak corresponding to ions of one or more second oligomers (e.g., trimers) are detected; and the enantiomeric purity of the analyte is determined by the ratio of the peak area of at least the first ion mobility peak to the peak area of the second ion mobility peak.
[0046] Unless otherwise indicated, the features of the aspects and / or embodiments indicated herein can, where technically feasible, be used both individually and in combination in all aspects and embodiments of the invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0047] Figure 1 [M+Na] is shown for racemic thalidomide and the pure R- and S-forms at 281 m / z + Results of a 20-pass cycling IMS experiment of ions (upper panel: R, middle panel: S, lower panel: racemic).
[0048] Figure 2 [2M+Na] at 539 m / z is shown + Results of 10 (a) and 20 (b) cycle IMS experiments of dimeric racemic thalidomide.
[0049] Figure 3 [2M+Na] is shown for racemic thalidomide and the pure R- and S-forms at 539 m / z + Results of a 10-pass cycling IMS experiment of ions (upper panel: R, middle panel: S, lower panel: racemic).
[0050] Figure 4 The [2M+Na] + Results of a 10-pass cycling IMS experiment of ions (from top to bottom: 20:1 S:R, 4:1 R:S, 2:1 R:S, racemic).
[0051] Figure 5 Shown is the variation of the thalidomide dimer mobility peak area as a function of the enantiomeric ratio (experimental and calculated values for the "ideal" dimer and the response factor adjusted dimer)
[0052] Figure 6 Shown is a post-migration mass spectrum showing the dimer ion signal and the monomer signal resulting from the dimer having dissociated.
[0053] Figure 7 a shows the ion mobility spectra (10 passes) of the dissociated sodium dimer ion at 281 m / z (upper graph) and the ion mobility spectra (10 passes) of the dimer ion at 539 m / z (lower graph). It can be seen that they all have the same ion mobility (i.e., the same elution time). Figure 7 b shows the corresponding [M+Na] + IMS data for a monomer (281 m / z), ie, not a dissociated dimer.
[0054] Figure 8 [2M+Li] at 523 m / z is shown + Results of a 10-pass cyclic IMS experiment of dimeric thalidomide. Top: R-thalidomide; Middle: S-thalidomide; Bottom: racemic thalidomide.
[0055] Fig. 9 a shows the ion mobility spectrum of the dissociated lithiated dimer ion after filtered migration at 265 m / z (10 passes). Top: R-thalidomide; middle: S-thalidomide; bottom: racemic thalidomide. Fig. 9 b shows the [M+Li] at 265 m / z for racemic thalidomide (lower panel) and the pure R-form (upper panel) and S-form (middle panel). + Results of a 10-pass IMS experiment of monomeric ions.
[0056] Fig.10Schematic representations of the methodology for determining which enantiomer is present in an enantiomerically pure sample (Scheme 1) and for determining which enantiomer is present in excess in an analyte comprising a mixture of enantiomers (Scheme 2) are shown.
[0057] Fig.11 a shows 25 passes of D / L (racemic), D-tryptophan and L-tryptophan (R about 325ΔCCS / CCS) [2M+H] + Cyclic ion mobility data, and Fig.11 b shows 40 passes of racemic propranolol, R-propranolol and S-propranolol (R about 411ΔCCS / CCS) [2M+Na] + Ion mobility data.
[0058] Fig.12 a shows 25 passes of various enantiomeric ratios of D-tryptophan and L-tryptophan [2M+H] + Cyclic ion mobility data, and Fig.12 b shows 40 passes of R-propranolol and S-propranolol at various enantiomeric ratios [2M+Na] + Ion mobility data.
[0059] Fig.13 Shown are the changes in the mobility peak areas of the tryptophan (upper panel) and propranolol (lower panel) dimers as a function of the enantiomeric ratio (experimental and calculated values for the "ideal" dimer and the response factor adjusted dimer).
[0060] Fig.14 10 pass cycle ion mobility data are shown for D-penicillamine, L-penicillamine and D / L (racemic) penicillamine. The dimer is a disulfide bridged covalent dimer. DETAILED DESCRIPTION
[0061] The determination of enantiomeric purity in the present invention is based on the surprising discovery that self-dimerization can be used for the diastereoisomer distinction in ion mobility separation. Enantiomers having the same collision cross section (CCS) and therefore interacting with the non-reactive background gas of the IMS device in the same manner cannot be distinguished in the absence of a chiral modifier or a chiral gas. Therefore, in achiral IMS, enantiomers cannot be separated. Even if two peaks are detected in the time of arrival distribution of a monomer enantiomer, this is not due to the monomer enantiomer being separated by ion mobility, but caused by other effects, such as two peaks can correspond to protomers.
[0062] Dimerization of a mixture of R- and S-enantiomers provides the following diastereomeric pairs of enantiomers: RR, SS, RS, and SR. RR dimers and SS dimers (i.e., homodimers) will have the same CCS (because they are enantiomers relative to each other), and RS dimers and SR dimers (i.e., heterodimers) will have the same CCS (because they are also enantiomers relative to each other). However, RR dimers and SS dimers will have different CCS from RS dimers and SR dimers because RR and SS are diastereomers of RS and SR. Therefore, for a mixture of R- and S-enantiomers, two ion mobility peaks for dimer ions in the ion mobility separation can be expected: one for RR dimers and SS dimers, and the other for RS dimers and SR dimers. For the ideal racemic mixture in which homodimer and heterodimer have the same association energy, it can be expected that two ion mobility peaks have equal intensity. In fact, a type of dimer may be due to formation mechanism (such as during electrospray) or due to their sensitivity to dissociation in different stages during the transfer by the instrument more unstable than another type (see discussion below). For enantiopure analyte, only one peak (corresponding to RR or SS, depending on the chirality of analyte) will be expected. The difference between the first ion mobility peak and the second ion mobility peak from the elution time of the ion mobility separator is caused by homodimer and heterodimer ions with different collision cross sections (therefore the ion mobility is different by the ion mobility separator).
[0063] The term "homodimer" or "homodimeric ion" herein refers to a dimer formed by the same enantiomer (i.e., RR or SS). Thus, a homodimer is a dimer of two (S)-enantiomers and / or two (R)-enantiomers (SS and / or RR). Another suitable term is a homochiral dimer. These may be ions I1 in the present disclosure. The term "heterodimer" or "heterodimer ion" herein refers to a dimer formed by different enantiomers (i.e., RS or SR). Thus, a heterodimer is a dimer of one (R)-enantiomer and one (S)-enantiomer, or a dimer of one (S)-enantiomer and one (R)-enantiomer. Another suitable term is a heterochiral dimer. These may be ions I2 in the present disclosure. Homodimers and heterodimers are formed by the same monomers (the only difference being the chirality of the monomers from which they are formed). In other words, homodimers and heterodimers are dimers formed from enantiomers of the same analyte molecule. Homodimers and heterodimers generally have the same m / z herein. Dimers may be referred to as "autodimers", ie they are obtained by self-dimerization.
[0064] The method described herein comprises the steps of detecting ions I1 forming a first peak in the IMS spectrum and ions I2 forming a second peak in the IMS spectrum. The ratio of the areas of the two peaks leads to the determination of the enantiomeric purity / excess of the analyte.
[0065] Thus, the ion causing the first peak may be referred to as I1, and the ion causing the second peak may be referred to as I2. It is not required that the second peak appear after the first peak (the term is often used herein to simply distinguish the two peaks), but in this context the second peak usually appears after the first peak (i.e., the elution time of the second peak is usually greater than the first peak). If the analyte is enantiopure (i.e., only one enantiomer), the ion I2 may not be present or detected. In fact, if only one enantiomer is present in the starting analyte, heterodimer ions will not be formed.
[0066] Ion I1 and ion I2 (e.g., homodimer ion and heterodimer ion) preferably have the same mass-to-charge ratio, i.e., "m / z". This m / z is usually the m / z of the dimer ion of the analyte, e.g., [2M+H] + 、[2M+Na] + 、[2M+Li] + etc. Thus, typically, although ions I1 and I2 have different ion mobilities (i.e., the peaks of ions I1 and I2 appear at different elution times from the IMS device), ions I1 and I2 have the same mass-to-charge ratio. m / z typically indicates that ions I1 and I2 are dimer ions. The method may include a step of determining that ions I1 and I2 correspond to dimer ions of the analyte based on m / z. Alternatively, the method may include a step of determining that ions I1 and I2 are dimer ions (or derived from dimer ions separated in an IMS device) based on known ion mobility data (e.g., known elution times from the IMS device). The method of the present invention may include a step of determining that ions I1 and I2 are dimer ions of the analyte based on a) m / z and / or b) ion mobility data (e.g., elution times).
[0067] Prior to ion mobility separation, the analytes are ionized using an ionization device (e.g., electrospray ionization). In the method of the present invention, there is no particular restriction on the nature of the ions. Typical ion adducts observed in IMS or mass spectrometry are suitable for the present method, for example, ions I1 and I2 may be [2M+H] + 、[2M+Na] + 、[2M+Li] + , [2M+K] + wait.
[0068] Dimerization of the analyte may occur in solution, for example prior to ionization, or during or after ionization.The propensity of certain compounds to form dimers enables diastereoisomer discrimination.
[0069] Dimerization can occur via any chemical interaction. For example, the dimer can be a hydrogen-bonded dimer. Alternatively, the dimer can be a covalently bonded dimer, such as a disulfide-linked dimer (these covalently bonded dimers are also often referred to herein as adducts, such as [2M+H] + 、[2M+Na] + 、[2M+Li] + , [2M+K] + etc.). In the examples and figures given below, thalidomide is used as the analyte. Dimerization of thalidomide has been discussed in the literature (see, for example, Smith et al.: Toxicol Res (Camb). 2018 Nov 1; 7(6): 1036–1047, or Tokunaga et al.: Sci Rep 8, 17131 (2018)). Tokunaga et al. showed hydrogen bonding of thalidomide dimers in the solid state as follows:
[0070]
[0071] It can be assumed that the dimer ions subjected to the ion mobility separation process in the present method have the same or similar structures. However, the present method is not limited thereto.
[0072] The analyte can be a chiral compound, such as a compound having at least one chiral center, preferably a compound having one or two chiral centers, more preferably a compound containing a single chiral center. "Analyte" herein can refer to a mixture of enantiomers of a compound, such as a mixture of R-enantiomers and S-enantiomers, or an enantiomerically pure or substantially enantiomerically pure compound. For example, if the analyte is thalidomide, the analyte can be a mixture of R-enantiomers and S-enantiomers of thalidomide. If there are more than one chiral center in the compound, it is preferred that the analyte is a mixture of enantiomers rather than a mixture of diastereomers (e.g., a mixture of SS and RR compounds, or a mixture of SR and RS compounds). The analyte can be any compound that can be analyzed by ion mobility spectrum / separation and can dimerize. The analyte can be a compound having at least one NH and / or OH group and at least one ether group (COC) or carbonyl group (C=O), because this promotes hydrogen bonding. The analyte can be a compound that can dimerize, for example, by hydrogen bonding. This concept has been shown to work well with thalidomide herein, but it should be understood that this approach is not only applicable to thalidomide. In fact, this approach has also been performed with tryptophan, propranolol, and penicillamine. This approach is only limited by the ability of the compounds to dimerize and is applicable to IMS.
[0073] The method is preferably performed in the absence of any chiral separating agent, for example in the absence of a chiral gas in an ion mobility separator, and / or in the absence of a chiral complexing agent. The method can be performed in the absence of any additional chiral moiety (i.e., in the absence of any chiral moiety except the chiral analyte). This is a particularly beneficial aspect of the present invention: the determination of enantiomeric purity can be performed purely based on the diastereoisomer distinction of the analyte dimer.
[0074] This method can be extrapolated to compounds with two or more chiral centers.
[0075] Analyte ions (i.e., ions I1 and I2) are separated based on ion mobility. Ions with a larger collision cross section (CCS) will travel slower through the ion mobility separator than ions with a smaller CCS. Therefore, the elution time of ions with a larger CCS is longer than the elution time of ions with a smaller CCS.
[0076] Homodimer ions and heterodimer ions have different CCS because homodimer ions are diastereomers of heterodimer ions. Therefore, heterodimer ions elute at different times from homodimer ions. In the case of thalidomide, the CCS of the heterodimer ion is And the CCS of the homodimer ion is However, the heterodimer ions of the analyte will not always have a larger CCS than the homodimer ions. This will depend on the specific geometry of the analyte molecule.
[0077] In the case of an ideal analyte (i.e., where the association energies of homodimers and heterodimers are the same), when the ion mobility peaks have different integrated areas, the ion mobility peak with the larger integrated area will correspond to the homodimer ion, and the ion mobility peak with the smaller integrated area will correspond to the heterodimer ion. For example, for an enantiomerically pure analyte (e.g., all R-enantiomers), only the homodimer (RR) peak will be detected. In a racemic mixture (i.e., 50:50 of R enantiomers and S enantiomers), for an ideal analyte, the area ratio of the two ion mobility peaks is 50:50, where the association energies of homodimers and heterodimers are the same (i.e., the homodimer ion mobility peak corresponding to SS dimers and RR dimers has the same area as the heterodimer ion mobility peak corresponding to RS dimers and SR dimers). Therefore, the ratio of the integrated peak area of homodimer ions to the integrated peak area of heterodimer ions can be in the range of 1:1 to 1:0. The integrated peak area of the second peak may be zero, ie the peak is not detectable (when an enantiopure or substantially enantiopure analyte is used).
[0078] In practice, the association energies of homodimers and heterodimers may be different. Thus, for a racemic mixture, the homodimer and heterodimer ion mobility peak areas may not have a 50:50 ratio. The ion mobility peak corresponding to the heterodimer may have a larger area than the ion mobility peak corresponding to the homodimer (as in the case of a racemic mixture of propranolol, see Fig.13 , bottom). The inventors have found that this can be explained by using a response factor "F".
[0079] Calculation of enantiomeric ratios from the relative peak areas of homodimeric and heterodimeric species
[0080] For an ideal situation, the theoretical relative peak areas of homodimer and heterodimer features can be calculated as follows.
[0081] I hom,rel =P RR + P SS (1)
[0082] I het,rel = P RS +P SR =2P RS (2)
[0083] Among them I hom,rel and I het,rel are the relative peak areas of the homodimer peak and heterodimer peak, respectively. RR, P SS , P RS and P SR is the probability of randomly forming the corresponding homodimers (RR and SS) and heterodimers (RS and SR).
[0084] P can be calculated as follows RR , P SS , P RS and P SR :
[0085]
[0086]
[0087] If we assume that the relative concentration of the R enantiomer [R] rel is in excess and the relative concentration of the S enantiomer [S] rel is 1 (e.g., in a solution with a 50:1 R:S enantiomer ratio, [R] rel =50 and [S] rel =1), then for the ideal case, substituting equations 3 to 6 into equations 1 and 2 gives I hom,rel and I het,rel for:
[0088]
[0089] In the non-ideal case where the homodimeric and heterodimeric species have different association energies, a response factor can be invoked:
[0090]
[0091] as well as
[0092]
[0093] Among them I hom,adj and I het,adj The relative intensity adjusted by the response factor as the ratio of the sum of these two values for the homodimer and heterodimer respectively (their sum will equal 1). hom and F het are the response factors for homodimers and heterodimers, respectively.
[0094] According to [R] as a representative of the enantiomeric ratio (ER) rel :
[0095]
[0096]
[0097] Equation 11 and Equation 12 in [R] rel is quadratic, and so rearrange [R] rel Two roots are given. The roots are [R] rel and 1 / [R] rel , which means that a non-decimal root should be taken. By using I hom,obs or I het,obs (Replacement Theory I hom,adj and I het,adj ) (which are the observed relative peak areas of the homodimer and heterodimer measured in the experiment, respectively) and F het (heterodimer response factor) to obtain the non-decimal root. Use I hom,obs :
[0098]
[0099] Similarly, using I het,obs :
[0100]
[0101] As mentioned above, it is assumed that the R enantiomer is in excess in Equations 7 to 14. If the S enantiomer is in excess, then [R] rel [S] can be used in all cases rel replace.
[0102] The response factor is determined empirically and applies to a specific chiral mixture under a given set of experimental conditions in an ion mobility mass spectrometer. In the case of an ideal mixture, F hom and F het will all be equal to 1. In a non-ideal mixture where the homodimer peak is more intense than the heterodimer peak, the major peak will have an F equal to 1 hom And the secondary peak will have an F less than 1 het In a non-ideal mixture where the heterodimer peak is stronger than the homodimer peak, F hom will be equal to 1 and F het will be greater than 1. Therefore, the response factor serves as a numerical indication of the deviation from the ideal mixture. For example, in the case of thalidomide, F hom =1 and F het =0.52. For thalidomide, F hom and F het Determined from an experiment in which the (R)-enantiomer and the (S)-enantiomer were mixed 1:1. The area of each peak was integrated, the area of the larger homodimer peak was normalized to 1, and the area of the smaller heterodimer was expressed as a decimal of the homodimer peak, giving a normalized value of 0.52. For example:
[0103]
[0104] Note that Equation 15 only applies to 1:1 (or racemic) mixtures.
[0105] By determining F from experimental data min or F het , can be targeted at a series of [R] rel Value Construction[R] rel Comparison of peak area (I hom,adj and I het,adj ). For unknown samples, I hom,obs and I het,obs And with I from the previous figure hom,adj and I het,adj Values are matched to determine [R] rel And thus determine the enantiomeric ratio.
[0106] The methods of the present invention may include the step of calculating the enantiomeric ratio or purity of the analyte using one or more of equations (1)-(15).
[0107] The response factor F can be calculated, for example, by determining the ratio of the peak area of the first dimer ion mobility peak to the peak area of the second dimer ion mobility peak for a known (e.g., racemic) mixture of the R enantiomer and the S enantiomer. The response factor can then be calculated using equations (1) to (15) above.
[0108] Once the response factor F het and F hom It is known that a single measurement of an analyte of unknown enantiomeric purity can determine the enantiomeric purity of the analyte. For example, this can be accomplished via calculation using the response factor and Equations 13 and 14, or via comparison with a calibration curve, such as Figure 5 Response factor F het and F hom The difference between the homodimer association energy and the heterodimer association energy can be accounted for. Therefore, the response factor enables calibration. The steps for determining the enantiomeric purity of the analyte may include:
[0109] - Calculating the enantiomeric purity from the ratio of the peak area of the first ion mobility peak to the peak area of the second ion mobility peak using a calibration function that accounts for the difference between the association energy of homodimer formation from monomers and the association energy of heterodimer formation from monomers.
[0110] The method may comprise an initial step of determining a calibration function from a sample of known enantiomeric purity.
[0111] The step of determining the enantiomeric purity of the analyte from the ratio of the peak area of the first ion mobility peak to the peak area of the second ion mobility peak may comprise the following steps:
[0112] a0) Optionally calculate the response factor F from a sample with known enantiomer concentration het and F hom ;
[0113] a) Using equations (1) to (15) above, the response factor F het and F hom and enantiomeric purity determined by the measured peak area ratios;
[0114] and / or
[0115] b) comparing the experimentally determined peak area ratios to a calibration curve (eg a calibration curve of relative peak areas versus enantiomer ratios).
[0116] Figure 5 The change in the ratio of ion mobility peak areas when the ratio of different thalidomide enantiomers is changed is shown. The figure shows the theoretical peak area versus enantiomeric ratio for the ideal homodimer and heterodimer, the experimental peak area versus enantiomeric ratio for the homodimer and heterodimer, and the theoretical peak area versus enantiomeric ratio for the ideal homodimer and heterodimer peaks corrected for the response factor. For the generation of the theoretical "ideal" solution, the contribution to the peak areas of the two features was simply calculated by the probability of dimer formation from a known mixing ratio of the two enantiomers (see calculation above). From Figure 5 As can be seen in the graph, the experimental data points closely match the response factor corrected theoretical data points. Accurate correlations can also be seen for tryptophan and propranolol ( Fig.13 ).
[0117] The dimer ion mobility peak with a larger integrated area may correspond to the homodimer ion (RR and / or SS) of the analyte, and the dimer ion mobility peak with a smaller integrated area may correspond to the heterodimer ion (RS and / or SR) of the analyte. However, depending on the association energy of the homodimer and heterodimer (reflected in the value of the response factor F), the opposite may also be the case. Fig.13 (Bottom) shows where the racemic mixture of R-propranolol and S-propranolol gives a higher ion mobility peak area for the heterodimer.
[0118] Thus, the method generally comprises the steps of determining that one ion mobility peak corresponds to a homodimer ion of the analyte (e.g., the peak with the largest integrated area) and determining that another ion mobility peak corresponds to a heterodimer ion of the analyte. This can be accomplished, for example, by assigning peaks obtained with enantiomerically pure analyte to homodimer ions, or by spiking the mixture with pure R-enantiomers or S-enantiomers of the analyte and observing which peak increases in relative intensity (e.g., see Fig.10 , Scheme 2). If only one ion mobility peak is present, the analyte can be considered to be substantially enantiopure (substantially all R or substantially all S). Because complete (i.e., 100%) enantiomeric purity can never actually be determined experimentally, the term "substantially" is used herein.
[0119] This method is particularly useful when it is known that one enantiomer is present in a larger amount in the starting material. The enantiomeric excess obtained by the method of the invention then enables the ratio of a specific enantiomer to be determined. However, the method can also be used to determine which enantiomer is present in excess in a non-racemic sample (see Fig.10 ). This can be done by performing a simple titration. Consider first the case of a pure enantiomer of unknown identity. The experimental homodimer ion mobility trace exhibits a single peak, such as Figure 3 If the user has a pure standard of either enantiomer available, two mixtures can be prepared, one with the unknown (R) enantiomer and one with the unknown (S) enantiomer. If the unknown is actually the (R) enantiomer, the ion mobility trace will not change after mixing with the (R) enantiomer. In the case of mixing with the (S) enantiomer, the ion mobility trace will show a similar pattern to Figure 3 The following figure or Figure 4 The second peak of feature 2 (i.e., the right-hand peak) in Fig.10 The same applies if the unknown sample is not completely pure. If more (S) is added, the intensity of the heterodimer peak will increase. If more (R) is added, the intensity of the homodimer peak will increase ( Fig.10 , below, "Scheme 2"). Thus, the method has another key utility of determining which enantiomer is in excess. Thus, the method may include the steps of determining which enantiomer is present in excess by adding one or both of the pure enantiomers to the analyte and measuring the change in relative peak intensity.
[0120] As the common case of weakly bonded structures, the dissociation of dimers into their component monomers may occur in the downstream of an ion mobility separator, such as before or during mass analysis. This means that the detected monomers can be shown as having the mobility of the dimers from which they dissociate. Therefore, although the dimer ions passing through the ion mobility separator obviously have a relatively high mass-to-charge ratio, mass spectral data may show that monomer ions (i.e. dissociated dimers) exist with a lower mass-to-charge ratio due to the dissociation of dimers. However, this does not affect the ability to calculate the enantiomeric purity of the sample, because dissociation occurs after the ion mobility separation, so the peak area ratio is unaffected. The peak representing the monomers derived from the dissociation of dimers will occur at the elution time identical with the dimer. Figure 7 A shows that the ion mobility spectra of dimer (figure below) and monomer (figure above) dissociated from dimer have the same peak area ratio.Users can filter data to display monomer (under lower m / z) or dimer (under higher m / z) from dissociating dimer.Depending on the level that dimer dissociates into monomer, users can, for example, select data formed by maximum ion (i.e., having the highest absolute peak intensity) and optimal resolution.For example, if relatively small proportion of dimer is dissociated into monomer in IMS device downstream and before mass detection, dimer may be more abundant than monomer in mass spectral data, and therefore the mass spectral data obtained under dimer m / z can be used to obtain IMS spectrum and determine ion mobility peak ratio.On the contrary, if relatively high proportion of dimer is dissociated into monomer in IMS device downstream and before mass detection, monomer will be relatively abundant in mass spectral data, and therefore the mass spectral data obtained under monomer m / z can be used to obtain IMS spectrum and determine ion mobility peak ratio.
[0121] Thus, ions detected by the mass analyzer (eg, ions I1 and I2) may be dimer ions or monomer ions derived from dissociation of dimer ions of the analyte downstream of the IMS device.
[0122] The methods disclosed herein can determine enantiomeric purity, i.e., the extent to which a sample contains an amount of one enantiomer greater than the amount of the other enantiomer. Other suitable terms include optical purity, enantiomeric ratio, etc. From enantiomeric purity (e.g., enantiomeric ratio), enantiomeric excess can be calculated, as is known in the art.
[0123] Ion mobility separation
[0124] As mentioned above, ion mobility separation (IMS) is used to separate monomers from dimers, and to separate a first dimer (e.g., I1) from a second dimer (e.g., I2). IMS is a recognized field, and any ion mobility separation instrument or method can be used for the present invention. For example, an IMS device can accumulate ions (e.g., in an ion trap) at the upstream end of an ion separation zone, and then pulse ions into the separation zone. Alternatively, an ion gate or other device can be used to introduce an ion packet into the separation zone. Once introduced into the separation zone, ions can be driven through the background gas arranged therein so that ions are separated according to their mobility through the background gas. Ions can be driven through the background gas by a static DC potential gradient or by repeatedly moving a DC potential barrier along the separation zone. Ions of different mobilities pass through the separation zone in different transmission times, therefore leaving and eluting from the IMS device at different times, and are detected at a downstream ion detector. The mobility of any given ion can then be determined based on the duration between the ion entering the separation zone (e.g., the time when the ion enters the separation zone from the ion trap pulse or the gated entry into the separation zone) and the time when the ion is detected. Alternatively, an IMS device may be used to separate ions only by mobility, rather than determining the mobility of the ions.
[0125] Although ions have been described as being driven through a (static) background gas in an IMS device in order to separate them by mobility, it is alternatively contemplated that the ions may be driven against an opposing gas flow, for example by a DC voltage gradient or DC travel potential. The gas flow may be in a direction from the outlet of the IMS device towards its inlet, or vice versa.
[0126] It is expected that the IMS device may have a linear ion guide in the ion separation region, along which ions are driven so as to separate ions according to ion mobility. Alternatively, the ion guide may take other forms, such as a closed-loop ion guide. For example, the ion guide may have an ion path that is substantially circular, elliptical or serpentine. Ions may be injected into the closed-loop ion guide, then driven the required number of times around the ion guide so as to separate dimers (and optionally monomers from dimers) by the required ion mobility resolution, and then ejected from the ion guide. For example, before being ejected, ions may be driven 2 to 100 times, 5 to 50 times, 5 to 30 times or 10 to 20 times around the ion guide. In the embodiment in which the ion guide is a closed-loop ion guide, it is preferred that the DC potential repeatedly travels along the ion guide so as to separate ions by mobility.
[0127] The ions eluted from the IMS device (or ions derived therefrom) can be transferred to a mass analyzer and mass analyzed, for example, by a time-of-flight (TOF) mass analyzer. The detector of the mass analyzer can be used as a detector to determine the elution time of the ions eluted from the IMS device. For example, the TOF mass analyzer can repeatedly mass analyze the ions eluted from the IMS device (or ions derived therefrom) at a relatively high rate so that the ions (or ions derived therefrom) leaving the IMS device are sampled multiple times during each ion mobility peak. The TOF mass analyzer is desirably operated at a sufficiently high rate so as to obtain enough data points to construct a mobility peak that faithfully represents the intensity distribution of the ions eluted from the IMS device as the elution time from the IMS device changes. The mass analyzer also obtains mass spectral data representing the mass-to-charge ratio of the detected ions. Based on the time when the mass analyzer detects the ions, the mass spectral data is associated with the elution time of the ions from the IMS device. Thus, the data acquired according to m / z can be filtered to obtain mobility data only for a specific m / z or a range of m / z. This filtered mobility data then represents the ion intensity as a function of elution time from the IMS device.
[0128] As described above, the dimer is separated and mass analyzed in an IMS device. Thus, the mass spectral data can be filtered to obtain only the mobility data corresponding to the m / z of the dimer. This reveals two mobility peaks for the dimer, the areas of which can then be compared to determine enantiomeric purity, as described above.
[0129] However, at least a certain proportion of the dimer may be dissociated into its constituent monomers downstream of the IMS device and before detection by the mass analyzer. Thus, the mass analyzer will obtain mass spectral data whose mass-to-charge ratio corresponds to that of the monomer, but sometimes corresponds to the elution time of the dimer. The mass spectral data can be filtered so as to obtain only mobility data corresponding to the m / z of the monomer. This also reveals two mobility peaks (corresponding to the mobility of the dimer), whose areas can then be compared to determine enantiomeric purity, as described above.
[0130] The mass spectrometer can be configured to select whether to use data filtered according to the m / z of the monomer or data filtered according to the m / z of the dimer to determine the enantiomeric purity of the analyte. For example, the selection can be made based on determining which of the spectral data has the highest ion abundance. Alternatively, both sets of filtered data can be used.
[0131] In order to simplify the required spectral processing, a mass filter may be provided upstream of the IMS device.The mass filter may be operated such that only ions having an m / z corresponding to the m / z of a dimer are transmitted to the IMS device.
[0132] It is important to use ion mobility separation in the present invention. First, before ion mobility separation, the tendency of the analyte to dimerize during ionization is beneficial. For example, the analyte tends to concentrate during electrospray, and the proportion of dimers in the association reaction will increase accordingly.
[0133] Second, dimers may have a strong ability to maintain dimerization during ionization and ion mobility separation. Given that the nature of the interactions (e.g., hydrogen bonding) that lead to dimerization is relatively weak, conventional chromatographic techniques (e.g., HPLC) are generally not suitable given, for example, interactions with stationary phases. If the dimer is hydrogen bonded, this bond is stronger in the gas phase after ionization, thus increasing the survival of the associated ions. In general, self-selection in other techniques (such as NMR or HPLC) is a dynamic equilibrium. For IMS, it is a dimer state that is kinetically captured in the gas phase.
[0134] Third, ion mobility separation is a particularly beneficial technique because it is rapid, easy, and adaptable. In particular, the gas pressure, gas type, and voltage used to separate ions in an IMS device are easily changed to suit the specific analytes being studied. As previously mentioned, the ability to determine enantiomeric purity is accomplished by differentiation of diastereomers of dimers resulting from self-dimerization.
[0135] "Subjecting an analyte to ion mobility separation" herein means separating the ions of the analyte in an ion mobility separator. The method may include the following steps: transmitting a plurality of ions of the analyte to an ion mobility separator; separating ions (i.e., ions I1 and ions I2) according to ion mobility; detecting ions that have left the ion mobility separator with a detector (e.g., a time-of-flight mass analyzer); recording the intensity of the ion signal output from the detector to generate recorded data, such as the first peak and the second peak herein; and determining the ion mobility of the detected ions.
[0136] The method may comprise the steps of detecting ions downstream of an ion mobility separator and determining the ion mobility of the ions transmitted through the ion mobility separator based on their detection times.
[0137] In the ion mobility spectra of the present invention, the x-axis generally corresponds to the elution time from the ion mobility separator, and the y-axis is the relative signal intensity.
[0138] Example
[0139] Material
[0140] All molecules studied were purchased from Sigma-Aldrich (Gillingham, UK) as follows: (R)-thalidomide (T151), (S)-thalidomide (T150), D-penicillamine (P4875), L-penicillamine (196312), L-tryptophan (T8941), D-tryptophan (T9753), (R)-propranolol (P0689) and (S)-propranolol (P8688).
[0141] Sample preparation
[0142] Solutions of (R)-thalidomide and (S)-thalidomide were prepared gravimetrically at a stock concentration of 1 mM in a 50:49:1 methanol / acetonitrile / formic acid (v / v%) solution. The stock solutions were diluted to 100 μM with 50:49.9:0.1 methanol / water / formic acid (v / v%) before direct infusion into the Z-spray ion source at a flow rate of 5 μL / min. Stock solutions of D-penicillamine and L-penicillamine were prepared in water at a concentration of 1 mM and diluted to 100 μM with 50:49.9:0.1 methanol / water / formic acid (v / v%) before direct infusion. L-tryptophan and D-tryptophan and (R)-propranolol and (S)-propranolol were prepared individually at a stock concentration of 1 mM in 50:49.9:0.1 water / acetonitrile / formic acid (v / v%) and diluted to 100 μM in the same solvent prior to analysis. To simulate a racemic mixture of the compounds, equal volumes of equimolar stock solutions of each enantiomer were mixed prior to ion mobility-mass spectrometry analysis. When necessary, a stock solution of 1 M NaCl or 1 M LiCl was added to a final concentration of 1 mM to promote the formation of sodium and lithium adducts.
[0143] Ion Mobility-Mass Spectrometry
[0144] All experiments were performed using a SELECT SERIES Cyclic IMS instrument (Waters Corporation, Wilmslow, UK). For high resolution multiple pass cyclic ion mobility analysis, the traveling wave pulse height was set to 12 V and the speed was 375 m / s. The number of passes was changed by selecting the appropriate 'single' number of times in the instrument control software. The pre- and post-migration voltages were minimized to preserve the dimer complex throughout the instrument; the capture and transfer collision voltages were 4 V and 2 V, respectively, the post-capture gradient was 5 V, the post-capture bias was 15 V, the helium cell inlet was 3 V, the helium cell bias was 22 V, the array pulse height in the ejection was 15 V, and the pre-transfer gradient was 5 V.
[0145] For CCS measurements, a traveling wave height of 15V was used, with a wave velocity of 375m / s. The form y = ax was used. b The instrument was calibrated for CCS using a power law of 1:1 (where a and b are constants determined by fitting a linear regression to a natural log-log plot of reduced CCS versus arrival time) with a large number of ions from the CCS Majormix calibration standard (Waters p / n 186008113).
[0146] Unless otherwise noted, arrival times are given herein in milliseconds (ms).
[0147] Software and data analysis
[0148] Data were manually processed using Masslynx v4.2 (SCN 1016) and determined using UNIFI 1.9.4. TW CCS N2 Values (both from Waters plc, Wilmslow, UK). For Gaussian fits of the arrival time distributions (ATDs), Microsoft Excel was used.
[0149] Multi-pass cyclic IMS of thalidomide - analysis of enantiomer (monomer) peaks
[0150] R-thalidomide, S-thalidomide and racemic thalidomide were passed 20 times around a closed-loop IMS device (also called a circulating IMS device) with a mobility resolution of 290 CCS / ΔCCS. All ions of thalidomide (monomer) eluted from the IMS device at the same time, indicating that the enantiomers could not be separated without a chiral modifier. The ion was characterized by TOF mass spectrometry as [M+Na] at 281 m / z + The CCS value of thalidomide [M+Na]+ was determined from the elution time measured from the IMS device as The results can be seen in Figure 1 middle.
[0151] Multi-pass cycling IMS of thalidomide - analysis of the dimer peak
[0152] The dimer of racemic thalidomide at 539 m / z (corresponding to [2M+Na] + ) showed two ion mobility peaks, which were consistent with two pairs of diastereoisomers (RR+SS and RS+SR). Figure 2 a (10 times around the IMS device) and Figure 2 Shown in b (20 passes through the cycle IMS device). Data were acquired by filtering the mobility-mass spectrometry data to 539 m / z. Figure 2 The CCS of peak 1 (left peak) and peak 2 (right peak) in a is and The results confirmed the diastereoisomer separation of the dimer by ion mobility.
[0153] Multiple-pass cycling IMS of thalidomide - determining which peak corresponds to the heterodimer (RS and SR) and which peak Corresponds to homodimers (SS and RR)
[0154] The 10-pass data for the racemic thalidomide dimer were compared to the 10-pass data for the individual enantiomers to determine which peaks corresponded to the heterodimers (RS and SR) and which peaks corresponded to the homodimers (SS and RR). The results are given in Figure 3 In the R-thalidomide sample, the dimer observed appears at the same IMS elution time as the S-thalidomide sample, which is consistent with the formation of enantiomer homodimers. These are at the same IMS elution time as peak 1 (left peak) in the racemic mixture, showing that peak 1 is composed of a mixture of RR dimers and SS dimers. This indicates that peak 2 (right peak) is composed of a mixture of RS dimers and SR dimers. Data are obtained by filtering the mobility-mass spectrometry data to 539m / z.
[0155] Multiple-pass cyclic IMS of thalidomide (different R- to S-ratios)
[0156] In this experiment, different IMS runs were performed with different R- to S-ratios of thalidomide. The results for ratios of 1:1 R:S (racemic), 2:1 R:S, 4:1 R:S, 20:1 S:R are given in Figure 4 As expected, changing the ratio of R- to S- in the mixture resulted in changes in the peak area of only dimer peak 1. The area of peak 1 increases with increasing ratios because of the increase in abundance of RR or SS (depending on whether R or S exceeds S or R, respectively).
[0157] Dimer mobility peak area as a function of enantiomeric excess
[0158] Figure 5 A plot of the peak areas of homodimers and heterodimers at various R:S or S:R ratios is shown. The plot shows the theoretical peak areas of ideal homodimers and heterodimers versus enantiomeric ratios, the experimental peak areas of homodimers and heterodimers versus enantiomeric ratios, and the theoretical peak areas of ideal homodimer and heterodimer peaks corrected for response factors versus enantiomeric ratios. For the generation of the theoretical "ideal" solution, the contributions to the peak areas of the two features were simply calculated by the probability of dimer formation from a known mixing ratio of the two enantiomers (see calculations above). From Figure 5 As can be seen, the experimental data points closely match the response factor corrected theoretical data points.
[0159] By comparing the peak areas of the heterodimer and homodimer, the enantiomeric purity can be calculated. If no second peak is detected, the analyte is (substantially) enantiomerically pure. If two peaks are present (i.e. one for the heterodimer and one for the homodimer), the enantiomeric purity can be calculated by using the response factor F or by comparison with a calibration curve (see Figure 5 ).
[0160] Possible dissociation of dimers after migration
[0161] In this work, it was noted that dimers can dissociate into monomers downstream of the mobility separator and before the ion detector. This means that the mass analyzer can detect ions with an m / z corresponding to a monomer, but with an ion mobility associated with a dimer (see Figure 7 a). This can lead to incorrect interpretation of the data. In particular, it may be wrongly assumed that the data show enantiomeric separation by ion mobility. An example of a mass spectrum showing dissociation of a dimer into monomers is Figure 6 . However, this does not affect the ability to accurately calculate the enantiomeric purity of the analyte because either a) complete dissociation is observed, or the heterodimer and homodimer dissociate at the same rate, in which case the ratio between the two peak intensities of the IMS data for the dissociated dimer is the same as for the dimer, or b) any difference in dissociation rate / ability between the heterodimer and homodimer can be accounted for by using an appropriate response factor F. Therefore, different response factors can be used when filtering the mass spectral data of the dimer versus the monomer to collect enantiomeric purity. The response factor must be determined experimentally. Figure 7 a shows that the ion mobility spectrum of the monomer derived from the dissociation of the dimer (281 m / z, upper panel) and the ion mobility spectrum of the dimer (539 m / z, lower panel) are the same.
[0162] Figure 7 The upper panel in a shows data filtered for 281 m / z. It includes 2 mobility peaks because the homodimer and heterodimer are separated in the IMS device and therefore elute at different times, but the dimer then dissociates into monomers downstream of the IMS device, which is why their signals are detected at 281 m / z (i.e., the m / z of the monomer). Figure 7 The lower panel of a shows the filtered data for 539 m / z, ie where the dimer does not dissociate and is therefore detected at a higher m / z.
[0163] Figure 7 b confirms that the monomer, which remained as a monomer through the IMS process, gave a single peak, as expected.
[0164] Results of lithium thalidomide
[0165] Figures 8 to 9 The same observations apply to lithiated thalidomide. Dimeric lithiated thalidomide (523 m / z) showed two peaks in the racemic mixture after 10 passes ( Figure 8 The corresponding monomer signal (265 m / z) from the dissociation of the dimer after migration also shows the same two peaks ( Fig. 9 a). As expected, monomeric lithiated thalidomide did not show any separation ( Fig. 9 b).
[0166] Applicability to other chiral systems
[0167] In order to evaluate the versatility of this method, the chiral compound D / L-tryptophan (tryp) [2M+H] + 、(R) / (S)-propranolol(prop)[2M+Na] + Similar multi-pass cIMS experiments were performed with D / L penicillamine (disulfide dimer) (see Figures 11 to 14 For D / L-tryptophan, 25 cIMS passes were performed, yielding a mobility resolution of approximately 325ΔCCS / CCS. The arrival time distribution ( Fig.11 a(i)) shows two partially resolved features, indicating that homodimers and heterodimers are formed in the same manner as thalidomide. The same experiment was performed on isolated D-tryp and L-tryp ( Fig.11 Aii and Fig.11 Aiii) produces the same single feature of the homodimer, which aligns with the more mobile ion population in D / L-tryp ATD (Feature 1 - left peak). This indicates that this is a homodimer, and Feature 2 (right peak) is a heterodimer.
[0168] For racemic-prop( Fig.11 B(i)), 40 cIMS passes were performed to obtain partial separation of the dimer ions, corresponding to a mobility resolution of 411ΔCCS / CCS, which is believed to exceed that of any other commercial ion mobility system. Again, for the separated (R)- and (S)-prop( Fig.11 B(ii) and Fig.11 B(iii)) Performing the same experiment produced a single feature; however, this time it aligned with the less mobile population in the racemic-prop ATD, indicating that in this case the homodimeric ion has the larger CCS. Although it is not surprising that the order of ionic mobility observed for the dimeric ion using this method is not fixed, it emphasizes that this method can be used in conjunction with computational methods to interrogate the structure of the dimeric ion in more detail.
[0169] Examining the ATDs of D / L-tryp and racemic-prop, we also noticed that the relative intensities of feature 1 and feature 2 in the ATDs of tryptophan and propranolol under 1:1 conditions ( Fig.11 Ai and Fig.11 Bi) indicates that their homodimer and heterodimer association energies are more similar than thalidomide. This indicates that for these two systems, the value of F is closer to 1.
[0170] Perturbations in the ratios of D / L-tryp and (R) / (S)-prop enantiomers reveal the dependence of the enantiomeric composition on the relative areas of the two features ( Fig.12 ), indicating that in the same manner as for thalidomide, given appropriate prior information, these ratios can be used to determine enantiomeric composition. For tryptophan and propranolol, Gaussian peak fitting was performed to determine relative peak areas. For each, empirical F values were determined from the 1:1 condition and applied to the other ratios, and excellent agreement was observed between the corresponding "adjusted ideal" curves and the experimental data ( Fig.13 ).
[0171] Another example of dimerization was found in penicillamine, which, instead of forming non-covalent electrospray-mediated dimers, formed spontaneous disulfide-linked dimers. A 10-pass cIMS experiment on a D / L-penicillamine mixture produced two features, only one of which was separated into the D- and L-forms ( Fig.14 ).
[0172] in conclusion
[0173] We show, consistent with theory, that racemic thalidomide (eg, [M+Na]+ or [M+Li]+) cannot be separated into its enantiomers by mobility using ion mobility in the absence of a chiral modifier.
[0174] Dimer from racemic thalidomide [2M+Na] + (or [2M+Li] + ) exhibited two species, RR, SS and RS, SR, in their ion mobility elution time distributions consistent with the formation of diastereomeric pairs of enantiomers.
[0175] Data obtained for individual enantiomers supports this. Changing the ratio of R or S increases the relative intensity of only one of the peaks. These dimer signals can be used to estimate enantiomeric excess based on the ratio of the peak areas.
[0176] Similar observations were obtained for tryptophan, propranolol, and penicillamine.
[0177] Any dimer dissociation downstream of the ion mobility separator can be accounted for, and in some cases where there is a high level of dissociation to the monomer, can be beneficial, as the m / z data for the dissociated dimer can have a higher signal intensity than the dimer.
Claims
1. A method for determining the enantiomeric purity of an analyte, the method comprising: ionizing the analyte to form a dimer ion; separating ions of different dimers of the analyte by ion mobility; detecting a first ion mobility peak corresponding to ions of the one or more first dimers and detecting a second ion mobility peak corresponding to ions of the one or more second dimers; and The enantiomeric purity of the analyte is determined from a ratio of a peak area of the first ion mobility peak to a peak area of the second ion mobility peak. 2 . The method of claim 1 , wherein the first ion mobility peak corresponds to a homodimer ion, and the second ion mobility peak corresponds to a heterodimer ion.
3. The method according to claim 2 includes determining that the peak area of the second mobility peak is equal to or less than the peak area of the first mobility peak, and therefore the first mobility peak corresponds to the ion mobility of the homodimer ion of the analyte, and the second mobility peak corresponds to the heterodimer ion of the analyte.
4. A method according to any preceding claim, wherein the first ion mobility peak corresponds to ions of at least two types of different dimers and / or the second ion mobility peak corresponds to ions of at least two types of different dimers.
5. A method according to any preceding claim, wherein each of the dimers is formed from gas phase monomer ions hydrogen bonded to each other.
6. A method according to any preceding claim, wherein the method is performed in the absence of a chiral selector and / or in the absence of a chiral complexing agent.
7. A method according to any preceding claim, wherein the step of separating ions is performed by an ion mobility separator; wherein ions eluted from the separator or ions derived therefrom are detected and mass analyzed in a mass analyzer to obtain mass spectral data representing the mass-to-charge ratio of the detected ions, and wherein based on the time at which the mass analyzer detects these ions, the mass spectral data of the ions detected at any given time are associated with the elution time of the ions from the separator.
8. A method according to claim 7, the method comprising filtering the mass spectrometry data so as to obtain only data corresponding to detected ions having a selected mass-to-charge ratio, thereby obtaining filtered data, the filtered data representing the intensity of the ions of the selected mass-to-charge ratio as a function of elution time from the separator; and wherein the step of detecting the first ion mobility peak and the second ion mobility peak comprises detecting the first ion mobility peak and the second ion mobility peak in the filtered data.
9. The method of claim 8, wherein the step of filtering the mass spectral data comprises filtering the mass spectral data so as to obtain only data corresponding to detected ions having a mass-to-charge ratio equal to the mass-to-charge ratio of one of the dimers.
10. The method of claim 8, wherein the step of filtering the mass spectral data comprises filtering the mass spectral data so as to obtain only data corresponding to detected ions having a mass-to-charge ratio equal to the mass-to-charge ratio of a monomer of one of the dimers.
11. A method according to any preceding claim, comprising mass filtering ions and transmitting only ions having a selected mass-to-charge ratio corresponding to the mass-to-charge ratio of one of the dimers to an ion mobility separator, which performs the step of separating the ions by the ion mobility.
12. A method according to any preceding claim, wherein the first ion mobility peak corresponds to a homodimer ion and the second ion mobility peak corresponds to a heterodimer ion, and wherein the step of determining the enantiomeric purity of the analyte comprises calculating the enantiomeric purity from the ratio of the peak area of the first ion mobility peak to the peak area of the second ion mobility peak using a calibration function, wherein the calibration function accounts for the difference between the association energy of homodimers formed by monomers and the association energy of heterodimers formed by monomers.
13. A method according to claim 12, comprising determining the calibration function from a sample of known enantiomeric purity.
14. A method according to any preceding claim, wherein the method is performed on a mass spectrometer having an ion mobility separator, and wherein the mass spectrometer has processing circuitry configured to calculate the ratio, such as by dividing the peak area of the first ion mobility peak by the peak area of the second ion mobility peak.
15. A mass spectrometer for determining the enantiomeric purity of an analyte, the mass spectrometer comprising: an ion source for ionizing an analyte; an ion mobility separator for separating ions by mobility; and A control circuit, the control circuit being configured to: controlling the ion source to ionize the analyte; controlling the ion mobility separator to separate ions of different dimers of the analyte by ion mobility and obtain mobility spectrum data; detecting a first ion mobility peak corresponding to ions of one or more first dimers in the mobility spectrum data, and detecting a second ion mobility peak corresponding to ions of one or more second dimers in the mobility spectrum data; and The enantiomeric purity of the analyte is determined from the ratio of the peak area of the first ion mobility peak to the peak area of the second ion mobility peak.
